Bret Jensen

|RSS

Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

By

Bret Jensen

 | Jun 14, 2017 | 10:00 AM EDT
But there are a few companies that have seen decent insider buying.
RMPIA
By

Bret Jensen

 | Jun 12, 2017 | 1:00 PM EDT
Tech meltdown provides an opportunity for rotation into undervalued sectors.
RMPIA
By

Bret Jensen

 | Jun 9, 2017 | 11:30 AM EDT
Diversification is the only risk management strategy that will work consistently.
By

Bret Jensen

 | Jun 7, 2017 | 10:00 AM EDT
Two are turnaround stories, and two are oversold.
By

Bret Jensen

 | Jun 5, 2017 | 11:30 AM EDT
Synergy Pharmaceuticals, Trevena and Egalet seem to have worst-case scenarios priced into them.
RMPIA
By

Bret Jensen

 | Jun 2, 2017 | 11:30 AM EDT
The two aren't among today's hot names, but are solid long-term growth plays.
RMPIA
By

Bret Jensen

 | May 31, 2017 | 11:13 AM EDT
Investors should be more cautious heading into the summer.
By

Bret Jensen

 | May 29, 2017 | 10:00 AM EDT
But there is hope, as the FDA has approved almost as many new compounds in 2017 as in all of 2016.
By

Bret Jensen

 | May 26, 2017 | 11:30 AM EDT
But there is hope, as the FDA has approved almost as many new compounds in 2017 as in all of 2016.
RMPIA
By

Bret Jensen

 | May 24, 2017 | 11:30 AM EDT
Valuations in some large-caps are compelling over the long term.

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.